Lenacapavir with Fostemsavir in a Multidrug-Resistant HIV-Infected Hemodialysis Patient

We report a hemodialysis MDR HIV-infected patient switched to fostemsavir with lenacapavir plus lamivudine for more than a year. She maintained a suppressed viral replication and did not present any clinical or biological drug-related side effects. The combination of lenacapavir plus fostemsavir loo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bigirimana, Ferdinand, Van den Wijngaert, Sigi, Fosso, Christelle, Stoffels, Karolien, Martin, Charlotte, Maillart, Evelyne, Clevenbergh, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599868/
https://www.ncbi.nlm.nih.gov/pubmed/37886135
http://dx.doi.org/10.1155/2023/8865265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599868/
https://www.ncbi.nlm.nih.gov/pubmed/37886135
http://dx.doi.org/10.1155/2023/8865265

Ejemplares similares